Jianping Bi

Zhuodaoquan South Road No.116
Wuhan, 430079, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications

Tumor treating fields combined with concurrent chemoradiotherapy for glioblastoma: A multi-institutional analysis.

Tumor treating fields combined with concurrent chemoradiotherapy for glioblastoma: A multi-institutional analysis.

Journal: iScience
Published: November 17, 2025

Efficacy and Safety of Neoadjuvant Stereotactic Body Radiotherapy (SBRT) Combined with Chemoimmunotherapy in Locally Advanced Breast Cancer: A Single-Center, Retrospective Pilot Study.

Efficacy and Safety of Neoadjuvant Stereotactic Body Radiotherapy (SBRT) Combined with Chemoimmunotherapy in Locally Advanced Breast Cancer: A Single-Center, Retrospective Pilot Study.

Journal: Breast cancer (Dove Medical Press)
Published: November 06, 2025

Neoadjuvant stereotactic body radiotherapy combined with chemotherapy and Ivonescimab for Chinese luminal-type breast cancer patients: study protocol for a single-arm, open-label, phase II trial.

Neoadjuvant stereotactic body radiotherapy combined with chemotherapy and Ivonescimab for Chinese luminal-type breast cancer patients: study protocol for a single-arm, open-label, phase II trial.

Journal: BMJ open
Published: September 11, 2025

Durable Tumor Control with Multi-Organ Immune-Related Adverse Events Following Immune Checkpoint Inhibitor and Sequential Radiotherapy in Locally Advanced NSCLC: A Case Report.

Durable Tumor Control with Multi-Organ Immune-Related Adverse Events Following Immune Checkpoint Inhibitor and Sequential Radiotherapy in Locally Advanced NSCLC: A Case Report.

Journal: ImmunoTargets and therapy
Published: August 10, 2025

Brain alterations detected by multiplex magnetic resonance imaging in nasopharyngeal carcinoma patients after induction chemotherapy: a longitudinal study.

Brain alterations detected by multiplex magnetic resonance imaging in nasopharyngeal carcinoma patients after induction chemotherapy: a longitudinal study.

Journal: PeerJ
Published: July 13, 2025

Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting.

Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting.

Journal: BMC cancer
Published: September 13, 2024

Evaluation of Radiotherapy Efficacy and Prognostic Analysis for Solid and Cystic Brain Metastases.

Evaluation of Radiotherapy Efficacy and Prognostic Analysis for Solid and Cystic Brain Metastases.

Journal: Cancer control : journal of the Moffitt Cancer Center
Published: July 19, 2024

Single-drug Chemotherapy Plus Immunotherapy as First-line Treatment for Stage Ⅳ Non-small Cell Lung Cancer Elderly Patients: A Phase II Clinical Trial UNICORN Study.

Single-drug Chemotherapy Plus Immunotherapy as First-line Treatment for Stage Ⅳ Non-small Cell Lung Cancer Elderly Patients: A Phase II Clinical Trial UNICORN Study.

Journal: Clinical lung cancer
Published: May 04, 2024

Dosimetric predictors of radiation pneumonitis in patients with prior immunotherapy exposure: A multi-institutional analysis.

Dosimetric predictors of radiation pneumonitis in patients with prior immunotherapy exposure: A multi-institutional analysis.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: May 31, 2023

Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy.

Integration of dosimetric parameters, clinical factors, and radiomics to predict symptomatic radiation pneumonitis in lung cancer patients undergoing combined immunotherapy and radiotherapy.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: May 10, 2023

Long-Term Outcomes of Nasopharyngeal Carcinoma by Epstein-Barr Virus Status in the Chinese Population: A Multicenter Investigation.

Long-Term Outcomes of Nasopharyngeal Carcinoma by Epstein-Barr Virus Status in the Chinese Population: A Multicenter Investigation.

Journal: Journal of clinical medicine
Published: January 29, 2023

Exploration of prognostic biomarkers in head and neck squamous cell carcinoma microenvironment from TCGA database.

Exploration of prognostic biomarkers in head and neck squamous cell carcinoma microenvironment from TCGA database.

Journal: Annals of translational medicine
Published: September 05, 2022
Showing 1-12 of 37

Last Updated: 09/26/2026